Latest news
Bharat Parenterals Ltd is Rated Sell - MarketsMojoMarketsMojo · Fri, 07 Aug 2026 21:09:26 GMTBharat Parenterals Q1FY27 loss widens to ₹3.6 crore on base effect - scanx.tradescanx.trade · Fri, 07 Aug 2026 07:00:00 GMTBharat Parenterals consolidated net profit declines 87.73% in the June 2026 quarter - Business StandardBusiness Standard · Thu, 06 Aug 2026 03:37:55 GMTBharat Parenterals re-appoints Hemang Shah as Executive Director for five years - scanx.tradescanx.trade · Wed, 05 Aug 2026 14:25:03 GMTBharat Parenterals Q1 FY27: Revenue Drops 19.2%, Subsidiaries Grow - WhalesbookWhalesbook · Wed, 05 Aug 2026 12:40:47 GMTBharat Parenterals Posts ₹3.56 Cr Consolidated Loss in Q1FY27 Despite Strong Standalone Profit - WhalesbookWhalesbook · Wed, 05 Aug 2026 12:16:44 GMT